Altamira Therapeutics Ltd. — All Filings
518 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
15-12G
15F-12B
20-F
20-F/A
25-NSE
424B3
424B4
424B5
6-K
6-K/A
8-A12B
8-A12B/A
8-K12G3
CERT
CERTNAS
CORRESP
CT ORDER
D
DRS
DRS/A
DRSLTR
EFFECT
F-1
F-1/A
F-1MEF
F-3
F-4
F-4/A
FWP
NT 20-F
POS AM
POS EX
RW
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| FWP | FWP | 0001193125-14-294629 | Aug 5, 2014 | — |
| F-1/A | AMENDMENT NO. 2 TO FORM F-1 | 0001193125-14-294415 | Aug 5, 2014 | — |
| CERTNAS | AUTO-GENERATED PAPER DOCUMENT | 9999999997-14-012412 | Jul 29, 2014 | — |
| 8-A12B | FORM 8-A | 0001193125-14-284547 | Jul 29, 2014 | — |
| CORRESP | — | 0001193125-14-284413 | Jul 29, 2014 | — |
| CORRESP | — | 0001193125-14-284403 | Jul 29, 2014 | — |
| F-1/A | AMENDMENT NO. 1 TO FORM F-1 | 0001193125-14-273405 | Jul 21, 2014 | — |
| UPLOAD | — | 0000000000-14-035963 | Jul 16, 2014 | — |
| CORRESP | — | 0001193125-14-267245 | Jul 14, 2014 | — |
| F-1 | F-1 | 0001193125-14-253454 | Jun 27, 2014 | — |
| UPLOAD | — | 0000000000-14-030901 | Jun 18, 2014 | — |
| DRS/A | — | 0000950123-14-006686 | Jun 6, 2014 | — |
| DRSLTR | — | 0000950123-14-003944 | Apr 18, 2014 | — |
| DRS/A | — | 0000950123-14-003942 | Apr 18, 2014 | — |
| UPLOAD | — | 0000000000-14-018834 | Apr 15, 2014 | — |
| DRS | — | 0000950123-14-003171 | Mar 18, 2014 | — |